Probiotic treatment with viable α‐galactosylceramide‐producing Bacteroides fragilis reduces diabetes incidence in female nonobese diabetic mice

Ähnliche Einträge

• Influence of sphingolipid enzymes on blood glucose levels, development of diabetes, and involvement of pericytes
  von: Karsten Buschard, et al.
  Veröffentlicht: (2024)
• Type 2 diabetes genetic risk and incident diabetes across diabetes risk enhancers
  von: Filipe A. Moura, et al.
  Veröffentlicht: (2024)
• An estimate of the need for continuous glucose monitoring in type 2 diabetes with intensive insulin treatment in secondary healthcare
  von: Christian Trolle, et al.
  Veröffentlicht: (2024)
• Slowing the progression of diabetic and non‐diabetic kidney disease: A summary of the current evidence base for sodium‐glucose co‐transporter‐2 inhibitors
  von: Viktor Rotbain Curovic, et al.
  Veröffentlicht: (2024)
• Declining incidence of hypoglycaemia in diabetes secondary to chronic pancreatitis: A nationwide cohort study from 2003 to 2022
  von: Line Davidsen, et al.
  Veröffentlicht: (2025)